Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients

被引:1
|
作者
Kanehira, Takahiro [1 ,2 ]
van Kranen, Simon [1 ]
Jansen, Tomas [1 ]
Hamming-Vrieze, Olga [1 ]
Al-Mamgani, Abrahim [1 ]
Sonke, Jan-Jakob [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiat Oncol, NL-1066 CX Amsterdam, Netherlands
[2] Hokkaido Univ Hosp, Dept Med Phys, Sapporo, Hokkaido, Japan
关键词
Dose accumulation; Head and neck cancer; NTCP model; Anatomical changes; Delivered dose; DEFORMABLE IMAGE REGISTRATION; ADAPTIVE RADIATION-THERAPY; ACUTE ORAL MUCOSITIS; QUALITY-OF-LIFE; ACCELERATED RADIOTHERAPY; RESPONSE ANALYSIS; RANDOMIZED-TRIAL; NTCP MODELS; IMRT; DYSPHAGIA;
D O I
10.1016/j.radonc.2021.09.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Normal tissue complication probability (NTCP) models are typically derived from the planned dose distribution, which can deviate from the delivered dose due to anatomical dayto-day variations. The aim of this study was to compare NTCP models derived from the planned and the delivered dose for head and neck cancer (HNC) patients. Material and method: 322 HNC patients who received radiotherapy with daily CBCT guidance were included in this retrospective study. The delivered dose was estimated by deformably accumulating dose from daily CBCT to planning anatomy. We used a Lyman-Kutcher-Burman NTCP model, to relate the equivalent uniform dose (EUD) of organs at risk (OAR) with oral mucositis, xerostomia and dysphagia respectively. We compared the model parameters and performances. Results: The median differences between planned and delivered EUD to the OARs were significantly larger for patients with toxicity than without for acute dysphagia (>G2 and >G3) and late dysphagia (>G3) (p < 0.05). Those differences resulted in small differences in steepness and agreement to the data between delivered-and planned-fitted NTCP curves, and the differences were not significant. The differences in AUC were less than 0.01. Conclusion: Differences between delivered and planned dose did not lead to significant differences in NTCP curves. The additional clinical relevance of NTCP models using accumulated dose for oral mucositis, xerostomia and dysphagia in HNC radiotherapy is likely to be limited. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 209-215
引用
收藏
页码:209 / 215
页数:7
相关论文
共 50 条
  • [1] Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation
    Heukelom, Jolien
    Kantor, Michael E.
    Mohamed, Abdallah S. R.
    Elhalawani, Hesham
    Kocak-Uzel, Esengul
    Lin, Timothy
    Yang, Jinzhong
    Aristophanous, Michalis
    Rasch, Coen R.
    Fuller, Clifton David
    Sonke, Jan-Jakob
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 142 : 100 - 106
  • [2] The Difference Between Planned and Delivered Dose for Head and Neck Cancer, and the Consequences for Normal Tissue Toxicity Probability
    Heukelom, J.
    Kantor, M. E.
    Mohamed, A. S.
    Elhalawani, H.
    Kocak, E.
    Lin, T.
    Williamson, R. T.
    Rasch, C. R.
    Fuller, C. D.
    Sonke, J. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E224 - E225
  • [3] Normal tissue complication probability during proton therapy for head & neck cancer patients
    Van Weerd, E.
    Jacobs, J.
    Hutschemaekers, S.
    Kroesen, M.
    Klaver, Y.
    Rodrigues, M.
    Werz, H.
    Keskin-Cambay, F.
    De Jong, M.
    Wiggenraad, R.
    Hoogeman, M.
    Habraken, S.
    Van Vulpen, M.
    Zindler, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S54 - S55
  • [4] Comparison of NTCP models between using planned and actual delivered dose for head and neck cancer
    Kanehira, T.
    Van Kranen, S. R.
    Hamming-Vrieze, O.
    Janssen, T.
    Sonke, J. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S165 - S166
  • [5] Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer
    Bertholet, Jenny
    Mackeprang, Paul-Henry
    Loebner, Hannes A.
    Mueller, Silvan
    Guyer, Gian
    Frei, Daniel
    Volken, Werner
    Elicin, Olgun
    Aebersold, Daniel M.
    Fix, Michael K.
    Manser, Peter
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 195
  • [6] Differences between planned and delivered maximum spinal cord dose in Head & Neck cancer patients
    Noble, D.
    Yeap, P.
    Harrison, K.
    Thomas, S.
    Parker, M.
    Burnet, N.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S480 - S481
  • [7] NTCP differences between planned and delivered dose in treatment for head and neck cancer
    Heukelom, J.
    Fuller, C.
    Kantor, M.
    Kauweloa, K.
    Rasch, C.
    Sonke, J. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S436 - S437
  • [8] A systematic review of the normal tissue complication probability models and parameters: Head and neck cancers treated with conformal radiotherapy
    Tajiki, Sareh
    Joya, Musa
    Gharekhani, Vahideh
    Richeson, Dylan
    Gholami, Somayeh
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (12): : 3146 - 3156
  • [9] Influence of set up error analysis on parotid normal tissue complication probability in patients treated with IMRT for head and neck cancer
    Marucci, L
    Marzi, S
    Giovinazzo, G
    Benassi, M
    Landoni, V
    Benassi, M
    Arcangeli, G
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S339 - S339
  • [10] Predicting Differences in Planned and Delivered Dose for Patients with Head and Neck Cancer Treated with Intensity Modulated Radiation Therapy
    Reese, A. S.
    Hou, J.
    Suntharalingam, M.
    D'Souza, W. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S800 - S800